Topics
~ Antitrust
~ Copyright
~ Database Protection
~ International Harmonization
~ Licensing
~ Litigation and Dispute Resolution
~ Patent Administration
~ Technology Transfer
~ Trade Secrets
~ Trademarks
Resources
~ Transcripts
~ Past Events
~ Publications
~ Upcoming Events
~ Web Sites
Sectors
~ Internet
~ Biotech/Pharma
~ E commerce
~ Agriculture
~ Business Methods
~ Software
|
|
Patent Administration
Technology Commercialization: Russian Challenges, American Lessons This collection of papers—by American and Russian specialists—addresses a variety of legal, regulatory, institutional, and financial issues that can promote or hinder technology commercialization. The book is the result of a series of workshops organized by the National Research Council with the Russian Academy of Sciences on commercialization of technologies, particularly those developed at research and educational institutions.
Technology Commercialization concludes with a list of actions, programs, and policies which warrant further consideration as Russia tries to improve the success of technology commercialization. This book will be of interest to those concerned with small-business development in post-communist states, university technology management, and comparative technology commercialization.
Also found in: Licensing ~ Trademarks ~ Technology Transfer |
|
The Children's Vaccine Initiative: Achieving the Vision The Children's Vaccine Initiative is an international endeavor to ensure that children throughout the world are immunized. This book notes that one of the best opportunities to address the growing problem of immunization in the United States and to improve the health of children in developing countries lies in marshaling the vaccine development and production efforts in the United States and abroad. The report contains information on the nature and status of vaccine development and production efforts in the United States and abroad, and it recommends ways to enhance participation in the International Children's Vaccine Initiative. Appendix A of the report details relevant intellectual property rights law.
Also found in: Licensing ~ Litigation and Dispute Resolution |
|
Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health On November 17, 2005, the Academies' Science, Technology and Economic Policy (STEP) Board and the Science, Technology, and Law Committee (STL) released a joint report, "Patenting and Licensing of Genomic and Protein Inventions." The report (commissioned by the National Institutes of Health) was presented by Committee co-chairs Shirley Tilghman, President of Princeton University, and Roderick McKelvie, Covington and Burling (and retired Judge, Federal District Court of Delaware) at a public briefing at the National Academies in Washington, DC. . The report documents trends in patenting and licensing in several categories of genetic and protein research, differences between US practices and those in Europe and Japan, and the impact of these practices on academic and corporate research directed at identifying disease mechanisms and therapeutic and diagnostic discoveries. Recommendations are addressed to the NIH and other government and private research funding agencies; the courts and the US Patent and Trademark Office; Congress; and the research community at large. The report includes the results of a new survey of bench scientists on their experience with intellectual property acquisition and access and sharing of data and research materials. affecting the economic well being of the United States.
Also found in: Licensing |
|
University-Industry Partnership Project The University-Industry Partnership Project is a collaborative effort between the National Council of University Research Administrators, The National Academies' Government-University-Industry Research Administrators, and the Industrial Research Institute. The objective of this project is to develop national acceptance of general principles governing intellectual property negotiations between U.S. universities and industry, thereby allowing the once-healthy relationship between education/training and commercial/economic development to reestablish itself in the U.S. In the last year, the project team has focused on strengthening university-industry research partnerships through a nationally accepted set of tools and guiding principles designed to support productive university-industry collaborations. The project is divided into four teams, each focused on developing work products that will be part of this national toolkit. the work products include: a set of Guiding Principles for University-Industry Partnerships, a working educational tool for practitioners that will allow for the construction of intellectual property agreements, a compilation of living studies that exemplify best practices in university-industry collaborations, and the development of an continuing forum for demonstrations of solutions to difficult IP problems.
Currently the U-I Partnership Project team is engaged in outreach activities with other stakeholder organizations to garner sign-on support for the Guiding Principles. On April 25, 2006 we will hold a National University-Industry Summit where we will kick off the next phase of the project which will focus specifically on developing the toolkit, tentatively named TurboNegotiations and creating a University-Industry Demonstration Partnership.
Also found in: Licensing ~ Technology Transfer | |
Patenting and Licensing of Genomic and Protein Inventions On November 17, 2005, the Academies' Science, Technology and Economic Policy (STEP) Board and the Science, Technology, and Law Committee (STL) released a joint report, "Patenting and Licensing of Genomic and Protein Inventions." The report (commissioned by the National Institutes of Health) was presented by Committee co-chairs Shirley Tilghman, President of Princeton University, and Roderick McKelvie, Covington and Burling (and retired Judge, Federal District Court of Delaware) at a public briefing at the National Academies in Washington, DC. .
The report documents trends in patenting and licensing in several categories of genetic and protein research, differences between US practices and those in Europe and Japan, and the impact of these practices on academic and corporate research directed at identifying disease mechanisms and therapeutic and diagnostic discoveries. Recommendations are addressed to the NIH and other government and private research funding agencies; the courts and the US Patent and Trademark Office; Congress; and the research community at large. The report includes the results of a new survey of bench scientists on their experience with intellectual property acquisition and access and sharing of data and research materials.
affecting the economic well being of the United States.
Also found in: Licensing | |
Nat'l Academies Press: Patents in the Knowledge-Based Economy his publication assembles nine original research studies commissioned by the STEP Board to inform judgments about some of the institutional and policy changes in the US patent system over the last 25 years. Included are papers assessing how the USPTO examination process affects the quality of issued patents, how the post-patent review system in the US ("patent re-examination") and Europe ("patent opposition") compare in operation, under what circumstances the benefits of an opposition system would outweigh the costs, what are the trends in patent litigation overall and in the semiconductor industry in particular, how and why the protection of software has shifted from copyrighting to patenting, what are the characteristics of Internet business method patents, and whether the proliferation of patents in biological research tools is inhibiting biomedical research. An introduction by the editors places this work in the context of other social science research on the patent system.
Also found in: Licensing ~ Litigation and Dispute Resolution ~ Technology Transfer |
|
A Patent System for the 21st Century, 2004 This report focuses on how well the system fulfills its mission of encouraging research, innovation, and the dissemination of knowledge and how it is adapting to rapid technological and economic changes. The panel concludes that the system has shown admirable flexibility in accommodating new technologies and reflecting the greater importance of intangible capital of all sorts. On the other hand, there is reason to be concerned about the quality of issued patents (whether they meet the statutory standards of novelty, utility, nonobviousness, and adequate written description), the resources available to the U.S. Patent and Trademark Office to keep up with the pace of change and volume of applications, features of U.S. law that inhibit the dissemination of information contained in patents and that raise the cost and uncertainty of litigation over patent validity and infringement, access to patented research technologies for basic non-commercial research, and redundancies and inconsistencies among national patent systems that raise the cost of global intellectual property protection.
Also found in: International Harmonization ~ Licensing ~ Litigation and Dispute Resolution ~ Technology Transfer |
|
Balancing the National Interest: U.S. National Security Export Controls and Global Economic Competition
The U.S. national security export controls system--which was instituted to impede Soviet acquisition of high technology from the West--is both necessary and appropriate. Balancing the National Interest provides a thorough analysis of this controls system, examining the current system of laws, regulations, international agreements, and organizations that control the international transfer of technology through industrial channels. Foreign Affairs calls it "the best on the subject to have been published in the 40 years that the United States has exercised controls on exports that might add to Soviet power."
Also found in: Licensing ~ Technology Transfer |
|
The Government Role in Civilian Technology As U.S. industry faces worldwide challenges, policymakers are asking questions about the role of the federal government--not only in promoting basic research but also in ushering new innovations to the marketplace. This book offers an expert consensus on how government and industry together can respond to the new realities of a global marketplace. The volume offers firm conclusions about policy and organizational changes with the greatest potential to improve our technological competitiveness--and presents three alternative approaches for a new federal role.
Also found in: Antitrust ~ Technology Transfer |
|
|